Tristel PLC
TSNLF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$275.5M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $275.50 Million |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.19 |
| Dividend yield | 3.28% |
| Earnings per Share | $0.14 |
| Beta | 0.35 |
| Outstanding Shares | 47,744,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 26.24 |
|---|---|
| PEG | 855.11 |
| Price to Sales | 2.87 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
October 19, 2026
EPS Estimate
$0.11
Consensus analyst estimateRevenue Estimate
$33.75 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 22, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Tristel PLC
267 employees
CEO: Christopher Paul Lee
Operating both within the United Kingdom and globally, Tristel plc specializes in the development, production, and distribution of products designed for infection control. Its business is structured into three primary divisions: Hospital...